Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Evidence review reconfirmed that no agents are recommended for the prevention of chemotherapy-induced peripheral neuropathy (CIPN). Duloxetine is the only agent that has evidence for use in the treatment painful CIPN, though the amount of benefit is limited.

Journal of Clinical Oncology